Alps Advisors Inc Geron Corp Transaction History

Alps Advisors Inc

$14.8 Billion
Q3 2024

A detailed history of Alps Advisors Inc transactions in Geron Corp stock. As of the latest transaction made, Alps Advisors Inc holds 455,654 shares of GERN stock, worth $1.82 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

455,654

Previous 462,671 1.52%

Holding current value

$1.82 Million

Previous $1.96 Million 5.46%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$4.17 - $4.99 $29,260 - $35,014	-7,017 Reduced 1.52%	455,654 $2.07 Million
Q2 2024 Aug 13, 2024	BUY	$3.1 - $5.09 $240,302 - $394,561	77,517 Added 20.13%	462,671 $1.96 Million
Q1 2024 May 14, 2024	BUY	$1.75 - $3.44 $46,151 - $90,719	26,372 Added 7.35%	385,154 $1.27 Million
Q4 2023 Feb 14, 2024	SELL	$1.74 - $2.31 $47,881 - $63,566	-27,518 Reduced 7.12%	358,782 $757,000
Q3 2023 Nov 14, 2023	BUY	$2.11 - $3.28 $26,014 - $40,439	12,329 Added 3.3%	386,300 $818,000
Q2 2023 Aug 14, 2023	BUY	$1.97 - $3.69 $169,396 - $317,295	85,988 Added 29.86%	373,971 $1.2 Million
Q1 2023 May 10, 2023	BUY	$2.14 - $3.4 $63,241 - $100,476	29,552 Added 11.44%	287,983 $624,000
Q4 2022 Feb 14, 2023	BUY	$2.03 - $2.42 $524,614 - $625,403	258,431 New	258,431 $625,000
Q2 2022 Aug 11, 2022	SELL	$1.19 - $1.65 $395,918 - $548,963	-332,705 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.99 - $1.6 $39,492 - $63,825	-39,891 Reduced 10.71%	332,705 $452,000
Q4 2021 Feb 09, 2022	SELL	$1.22 - $1.72 $24,827 - $35,002	-20,350 Reduced 5.18%	372,596 $455,000
Q3 2021 Nov 15, 2021	SELL	$1.2 - $1.5 $31,995 - $39,994	-26,663 Reduced 6.35%	392,946 $538,000
Q2 2021 Aug 11, 2021	SELL	$1.25 - $1.83 $177,635 - $260,057	-142,108 Reduced 25.3%	419,609 $592,000
Q1 2021 May 07, 2021	BUY	$1.52 - $2.1 $828 - $1,144	545 Added 0.1%	561,717 $888,000
Q4 2020 Feb 03, 2021	BUY	$1.55 - $2.05 $869,816 - $1.15 Million	561,172 New	561,172 $892,000

Others Institutions Holding GERN

# of Institutions

275

Shares Held

491M

Call Options Held

1.87M

Put Options Held

690K

View Full List

About GERON CORP

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.51B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

More about GERN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account

Alps Advisors Inc Geron Corp Transaction History